Vice President, Clinical Sciences
Sangamo Therapeutics
Brisbane, California, United States
Ben Hsu, MD, PhD, is Vice President, Clinical Sciences at Sangamo Therapeutics, a genomic medicines company developing therapies for a variety of disease conditions. Ben oversees several cell therapy programs. Ben is the clinical lead of the BIVV003 clinical trial program in sickle cell disease since Sangamo regained rights to BIVV003 in 2022.
Disclosure information not submitted.
Autologous Cell Therapy Involving Zinc Finger Nuclease-mediated Gene Editing
Friday, June 16, 2023
4:25 PM – 4:35 PM East Coast USA Time
Friday, June 16, 2023
5:15 PM – 5:30 PM East Coast USA Time